ArticleJournal of experimental & clinical cancer research : CR2017

TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.

Ming-Zhi Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.